Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Aliada Therapeutics Inc | -6.97% | 1.40bn |
Celsius Therapeutics Inc | 2.11% | 250.00m |
Cerevel Therapeutics Holdings Inc | 20.88% | 8.70bn |
ImmunoGen Inc | 26.18% | 10.22bn |
Data delayed at least 15 minutes, as of Nov 22 2024 14:42 GMT.